Immunogenicity of licensed influenza A (H1N1) 2009 monovalent vaccines in HIV-infected children and youth

Robert F. Pass, Sharon Nachman, Patricia M. Flynn, Petronella Muresan, Terence Fenton, Coleen K. Cunningham, William Borkowsky, James B. McAuley, Stephen A. Spector, Elizabeth Petzold, Wende Levy, George K. Siberry, Ed Handelsman, L. Jill Utech, Adriana Weinberg

Research output: Contribution to journalArticle

Abstract

Background. With the emergence of pandemic influenza A (pH1N1) in 2009, children and youth infected with human immunodeficiency virus (HIV) were vulnerable because of immunologic impairment and the greater virulence of this infection in young persons. Methods. A multicenter study of the immunogenicity of 3 licensed influenza A (H1N1) monovalent vaccines (1 live attenuated and 2 inactivated) was conducted in children and youth with perinatal HIV infection, most of whom were receiving ≥3 antiretroviral drugs, had CD4% ≥15, and plasma HIV RNA levels

Original languageEnglish (US)
Article numberpit040
Pages (from-to)352-360
Number of pages9
JournalJournal of the Pediatric Infectious Diseases Society
Volume2
Issue number4
DOIs
Publication statusPublished - Dec 1 2013
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Infectious Diseases
  • Pediatrics, Perinatology, and Child Health

Cite this

Pass, R. F., Nachman, S., Flynn, P. M., Muresan, P., Fenton, T., Cunningham, C. K., ... Weinberg, A. (2013). Immunogenicity of licensed influenza A (H1N1) 2009 monovalent vaccines in HIV-infected children and youth. Journal of the Pediatric Infectious Diseases Society, 2(4), 352-360. [pit040]. https://doi.org/10.1093/jpids/pit040